Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan

被引:0
|
作者
Shigeaki Ohno
Itsuro Umebayashi
Miyuki Matsukawa
Takashi Goto
Toshiro Yano
机构
[1] Hokkaido University,Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine
[2] Aishin Memorial Hospital,Department of Ophthalmology
[3] Mitsubishi Tanabe Pharma Corporation,Ikuyaku. Integrated Value Development Division
[4] Mitsubishi Tanabe Pharma Corporation,Ikuyaku. Integrated Value Development Division
关键词
Behçet’s disease; Uveoretinitis; Biological therapies; Infliximab; Postmarketing surveillance; Safety; Efficacy; Associated factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
    Elalouf, Ofir
    Elkayam, Ori
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1719 - 1726
  • [22] Long-term efficacy and safety of infliximab treatment of ankylosing spondylitis
    Boeger, CA
    Wittwer, H
    Schattenkirchner, M
    Kellner, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 64 - 64
  • [23] Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behcet's disease
    Ueda, Sho
    Akahoshi, Mitsuteru
    Takeda, Atsunobu
    Inoue, Yasushi
    Omoto, Aya
    Ayano, Masahiro
    Kimoto, Yasutaka
    Mitoma, Hiroki
    Arinobu, Yojiro
    Niiro, Hiroaki
    Tsukamoto, Hiroshi
    Horiuchi, Takahiko
    Hikita, Shin-Ichi
    Fukuhara, Takako
    Ishibashi, Tatsuro
    Sonoda, Koh-Hei
    Akashi, Koichi
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (01) : 9 - 15
  • [24] Long-Term Efficacy of Infliximab Treatment in Pediatric Crohn's Disease in the Netherlands
    de Bie, Charlotte
    Hummel, Thalia
    Kindermann, Angelika
    Kokke, Freddy
    Damen, Gerard
    Kneepkens, Corneille M.
    van Rheenen, Patrick
    Schweizer, Joachim
    Hoekstra, Hans
    Norbruis, Obbe
    Ten, W. Tjon A.
    Vreugdenhil, Anita
    Deckers-Kocken, Judith M.
    Gijsbers, Carolien F.
    Escher, Johanna C.
    de Ridder, Lissy
    GASTROENTEROLOGY, 2010, 138 (05) : S302 - S302
  • [25] LONG-TERM EFFICACY OF INFLIXIMAB TREATMENT IN PEDIATRIC CROHN'S DISEASE IN THE NETHERLANDS
    de Bie, C. I.
    Hummel, T. Z.
    Kindermann, A.
    Escher, J. C.
    de Ridder, L.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E210 - E210
  • [26] MAINTENANCE OF REMISSION WITH INFLIXIMAB IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: EFFICACY AND SAFETY OF LONG-TERM TREATMENT
    Petrolati, A.
    Nasoni, S.
    Altavilla, N.
    Cipolla, R.
    Fenderico, P.
    Forlini, G.
    Rossi, Z.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S134 - S134
  • [27] Successful treatment with infliximab for refractory para-ileostomal ulceration in a patient with Behҫet’s disease
    Ishioka M.
    Onochi K.
    Suzuki Y.
    Sawaguchi M.
    Hatakeyama N.
    Koizumi S.
    Matsuhashi T.
    Jin M.
    Ohnishi H.
    Clinical Journal of Gastroenterology, 2015, 8 (4) : 193 - 196
  • [28] Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusions
    Adán A.
    Hernandez V.
    Ortiz S.
    Molina J.J.
    Pelegrin L.
    Espinosa G.
    Sanmartí R.
    International Ophthalmology, 2010, 30 (5) : 577 - 581
  • [29] Long-term infliximab treatment for Behcets's disease
    Takamoto, Mitsuko
    Kaburaki, Toshikatsu
    Numaga, Jiro
    Fujino, Yujiro
    Kawashima, Hidetoshi
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2007, 51 (03) : 239 - 240
  • [30] Efficacy and safety in the long-term treatment with infliximab of psoriasis and psoriatic arthritis
    Papoutsaki, M.
    Chimenti, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S7 - S7